NanoporeDx is developing a 30-minute test for diagnosing bacterial infections.

Currently, there are no testing strategies available to diagnose a bacterial infection during a patient’s examination. Gold standard bacterial diagnostics take days, “cutting-edge” tests just hitting the market still require hours. Physicians wanting to treat a patient immediately therefore have no choice but to make antibiotic decisions solely based on a patient’s symptoms. This is an incredibly inefficient process; it has lead to 50% of all antibiotics prescribed in the US being either not needed or suboptimal as prescribed. This staggering antibiotic misuse is the main cause of antibiotic resistance, increases healthcare costs by $35B annually, and worsens patient outcomes.

The test NanoporeDx is developing will move beyond diagnoses made on symptoms alone by determining if an infection present, and then providing comprehensive details on the infection, in only 30 minutes. This will inform physicians first seeing a patient what antibiotic, if any, is needed. Only NanoporeDx’s core technology, the iNDxer, is sensitive, rapid, and portable enough to perform such microbiology lab quality testing right at the patient’s side.



Increased Sensitivity

Enables detection without the long culture times required in other methods to increase the number of infectious microbes in a clinical sample before testing.


Allows for point-of-care testing eliminating transit time to a microbiology lab.